nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis
|
Kanters, Steve |
|
2017 |
4 |
10 |
p. e433-e441 |
artikel |
2 |
Cost-effectiveness of early identification of HIV infection
|
Nichols, Brooke E |
|
2017 |
4 |
10 |
p. e431-e432 |
artikel |
3 |
Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
|
Baggaley, Rebecca F |
|
2017 |
4 |
10 |
p. e465-e474 |
artikel |
4 |
Efficacy of oral pre-exposure prophylaxis (PrEP) for HIV among women with abnormal vaginal microbiota: a post-hoc analysis of the randomised, placebo-controlled Partners PrEP Study
|
Heffron, Renee |
|
2017 |
4 |
10 |
p. e449-e456 |
artikel |
5 |
Household survey of HIV incidence in Rwanda: a national observational cohort study
|
Nsanzimana, Sabin |
|
2017 |
4 |
10 |
p. e457-e464 |
artikel |
6 |
How will we get there? How will we know?
|
Eaton, Jeffrey W |
|
2017 |
4 |
10 |
p. e429-e430 |
artikel |
7 |
Paediatric HIV: the unfinished business
|
Penazzato, Martina |
|
2017 |
4 |
10 |
p. e425-e427 |
artikel |
8 |
Second-line antiretroviral therapy: so much to be done
|
Assefa, Yibeltal |
|
2017 |
4 |
10 |
p. e424-e425 |
artikel |
9 |
Vaginal dysbiosis and pre-exposure prophylaxis efficacy
|
van de Wijgert, Janneke |
|
2017 |
4 |
10 |
p. e427-e429 |
artikel |
10 |
Would you like an HIV test?
|
The Lancet HIV, |
|
2017 |
4 |
10 |
p. e423 |
artikel |
11 |
Xpert HIV-1 point-of-care test for neonatal diagnosis of HIV in the birth testing programme of a maternity hospital: a field evaluation study
|
Technau, Karl-Günter |
|
2017 |
4 |
10 |
p. e442-e448 |
artikel |